510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K250884Substantially Equivalent

0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe

Becton Dickinson & Co, Franklin Lakes NJ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K250884 is the FDA 510(k) clearance record for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe, a class II device, cleared for Becton, Dickinson and Company on under FDA product code NGT (Saline, Vascular Access Flush). FDA's definition for product code NGT reads: "Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use". FDA records list 345 510(k) clearances for Becton, Dickinson and Company, from to . As of , FDA records show no recalls naming K250884.

Clearance record

Decision date
Received
(253 days to decision)
Product code
NGT Saline, Vascular Access Flush
Regulation
21 CFR 880.5200
Device class
Class II
Review panel
General Hospital
Applicant
Becton, Dickinson and Company 1 Becton Dr., Franklin Lakes NJ
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NGT

Trailing 12 months
1 clearance under product code NGT in the twelve months to October 2026, December 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code NGT, trailing twelve months
MonthClearances
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260